Scotiabank Reiterates Sector Outperform Rating on INmune Bio Inc. (INMB)
Tweet Send to a Friend
Scotiabank analyst George Farmer reiterated a Sector Outperform rating and $22.00 price target on INmune Bio Inc. (NASDAQ: INMB).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
